Search

Your search keyword '"Valenti, Luca"' showing total 1,637 results

Search Constraints

Start Over You searched for: Author "Valenti, Luca" Remove constraint Author: "Valenti, Luca"
1,637 results on '"Valenti, Luca"'

Search Results

1. Resmetirom and Metabolic Dysfunction-Associated Steatohepatitis: Perspectives on Multidisciplinary Management from Global Healthcare Professionals

2. A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease

4. A multisociety Delphi consensus statement on new fatty liver disease nomenclature

5. A multisociety Delphi consensus statement on new fatty liver disease nomenclature.

6. Elevated plasma hepcidin concentrations are associated with an increased risk of mortality and nonfatal cardiovascular events in patients with type 2 diabetes: a prospective study

7. MetSCORE: a molecular metric to evaluate the risk of metabolic syndrome based on serum NMR metabolomics

9. Real-world evidence on non-invasive tests and associated cut-offs used to assess fibrosis in routine clinical practice

10. Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women

11. Author Correction: Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women

15. Global burden of metabolic diseases, 1990–2021

16. Stratified analyses refine association between TLR7 rare variants and severe COVID-19

17. Exploring the impact of the PNPLA3 I148M variant on primary human hepatic stellate cells using 3D extracellular matrix models

21. Incidence, microbiological and immunological characteristics of ventilator-associated pneumonia assessed by bronchoalveolar lavage and endotracheal aspirate in a prospective cohort of COVID-19 patients: CoV-AP study

23. Consensus Statement on the definition and classification of metabolic hyperferritinaemia

24. Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy

27. Implementation of a liver health check in people with type 2 diabetes

28. Comparison of the severity of metabolic, liver and cardiovascular damage in NAFLD patients attending the hepatology clinic over the last three decades

29. A multisociety Delphi consensus statement on new fatty liver disease nomenclature

30. SIRT5 rs12216101 T>G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease

31. Author Correction: Consensus Statement on the definition and classification of metabolic hyperferritinaemia

33. Impact of PNPLA3 rs738409 Polymorphism on the Development of Liver-Related Events in Patients With Nonalcoholic Fatty Liver Disease

34. Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver disease

35. A global research priority agenda to advance public health responses to fatty liver disease

36. Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis

37. Contributors

39. The role of immune suppression in COVID-19 hospitalization: clinical and epidemiological trends over three years of SARS-CoV-2 epidemic

40. Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis

41. Cholesterol Stabilizes TAZ in Hepatocytes to Promote Experimental Non-alcoholic Steatohepatitis.

43. TOP-301 Impact of clonal hematopoiesis of indeterminate potential on hepatocellular carcinoma in steatotic liver disease

44. FRI-290 Evaluation of ChatGPT as a counselling tool for Italian-speaking MASLD patients: assessment of accuracy, completeness and comprehensiveness

46. WED-293 Effectiveness of on different models of care based on Fibrosis-4 and/or liver stiffness measurement for the screening of patients with type 2 diabetes mellitus at risk of advanced liver disease

48. WED-130 Prevalence and predictors of porto-sinusoidal vascular disorder in patients with persistent and unexplained gamma-glutamyl transferase elevation: a multicenter study

50. TOP-144-YI Heterozygosity for rare Apolipoprotein B variants predispose to severe metabolic associated steatotic liver disease

Catalog

Books, media, physical & digital resources